DUBLIN--(BUSINESS WIRE)--Sep 11, 2018--The "Global Biologics Manufacturing Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The Global Biologics Manufacturing Market to grow at a CAGR of 9.11% during the period 2018-2022.

Global Biologics Manufacturing Market 2018-2022 has been prepared based on an in-depth market analysis with inputs from industry experts. The report also includes a discussion of the Key vendors operating in this market. To calculate the market size, the report considers the cost incurred for in-house manufacturing of biologics and the revenue generated by contract manufacturers of biologics across the globe.

According to the report, one driver influencing this market is the introduction of new biologic drugs for treating diseases. There is a growing demand for biologics for effective treatment of diseases as synthetic drugs have several limitations.

One trend affecting this market is the rise in partnerships between traditional biopharma companies and biotechnology startups. The significant growth of the biologics industry and biotech companies in the past few years has encouraged several major traditional biopharma companies to collaborate with biotechnology startups to develop novel biologics drugs.

Further, the report states that one challenge affecting this market is the high cost of branded drugs is deterring market growth. A key factor restraining the growth of the global biologics manufacturing market is the high cost of medication.

Market trends

Rise in partnerships between traditional biopharma companies and biotechnology startups Growing outsourcing of biologics manufacturing Increase in FDA approvals for new biologics products

Key vendors

Amgen F. Hoffmann-La Roche Johnson & Johnson Merck & Co Pfizer

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Market Sizing

Part 06: Five Forces Analysis

Part 07: Market Segmentation By Technology

Part 08: Market Segmentation By Product

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/d5g6mb/global_biologics?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005605/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biopharmaceuticals

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/11/2018 11:59 AM/DISC: 09/11/2018 11:59 AM

http://www.businesswire.com/news/home/20180911005605/en